Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease

NCT02719496 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02719496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02719496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2016
Completion date
April 30, 2018
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal disorders in parkinson's disease